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Supplementary Information 
Supplementary Materials and Methods 
Tf-PEG-OPSS Synthesis. Human holo-Tf (Sigma, 100 mg, 2 mg/ml) was added to 8 
molar excess NHS-PEG5k-OPSS (Creative PEGworks) in a 10 mM sodium phosphate 
buffer, pH 9.0.  The reaction proceeded for 90 minutes under gentle rocking at room 
temperature.  Excess PEG was removed and the Tf was concentrated in a 50 kDa MWCO 
centrifugal filter (Amicon, Millipore) after which the monoPEGylated fraction was 
separated by HPLC (1200 series, Agilent, using two TOSOH TSK gel G3000swxl 
columns in series) followed by Hydrophobic Interaction Chromotography (HIC) (using 
an AKTA prime plus FPLC system (GE Healthcare) and a 5 ml HiTrap Phenyl column 
(GE Healthcare)).  HIC was run with a high salt buffer of 1 M Ammonium Sulfate with 
50 mM Sodium Phosphate (pH 7.0), and a low salt buffer of the former only.  
MonoPEGylated fractions from HIC were confirmed by Matrix Assisted Laser 
Desorption Ionization Time-Of-Flight mass spectroscopy – MALDI-TOF (Voyager DE 
PRO PerSeptive Biosystems) using a sinapic acid matrix.  Iron citrate (2.5 mole excess) 
in 100 mM sodium bicarbonate was added to the monoPEGylated fraction and incubated 
with gentle stirring for 2.5 hours at room temperature.  The excess iron was removed with 
six washes of 100 mM sodium bicarbonate through a 50 kDa centrifugal filter.  The iron 
loading content of Tf was measured by UV-VIS through the ratio of A465/A280 and was 
compared to the same ratio of the original non-processed holo-Tf.  A465/A280 ratios above 
0.8 were considered to be adequate evidence for iron loading.  Tf-PEG-OPSS was stored 
at 4 oC in a 50 mM sodium bicarbonate buffer pH 8.0.  
Au-PEG-Tf Synthesis. Tf-PEG-OPSS was added in the indicated molar fraction (e.g. 10 
mole excess Tf added to gold for a 10 Tf per particle formulation) to gold cores of 5 nm, 
20 nm, and 50 nm (BBI International).  The reaction was stirred for at least 90 minutes, 
and a large excess (~10,000 molar excess) of 5 kDa mPEG-SH (Laysan Bio) was added 
for a remaining 90 minutes.  The resulting 45 nm and 80 nm nanoparticles were pelleted 
at 20,000 g for 10 minutes, and the pellets were resuspended in 1 ml of water, sonicated 
for 10 minutes, and repelleted.  This washing procedure was repeated two times.  In lieu 
of centrifugation for the 20 nm nanoparticles, a 100 kDa MWCO spin filter (Amicon) 
was used to removed excess PEG and concentrate the nanoparticles.  
 
Dynamic Light Scattering (DLS):  Particle sizes and zeta potentials were measured with 
a Brookhaven Instruments DLS and ZetaPALS.  Hydrodynamic diameters were 
measured in PBS and averaged from three runs at two minutes each.  Zeta potentials were 
run in 1.5 mM KCl (pH 7.0) and averaged from three runs at a target residual of 0.02.  
Measurements were reported as the average +/- one standard deviation.     
 
Nanoparticle Tracking Analysis (NTA): NTA measurements were performed with a 
NanoSight NS500 (NanoSight).  All measurements were taken in 50 mM sodium 
phosphate (pH 7.0) over a time of 60 s with manual shutter and gain adjustments.  The 
data is reported as the mode with one standard deviation of three runs on the same 
sample. 
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Nanoparticle-Cell Binding Assay.  Neuro2A cells (ATCC) were cultured for at least 
one week in DMEM, 10% FBS and PEN/STREP.  Cells were washed once with cold 
PBS, scraped from the flask and suspended in cold PBS, fixed for 15 minutes in cold BD 
Cytofix (BD Biosciences) and resuspended in PBS with 4% BSA.  Increasing 
concentrations of nanoparticles were incubated with 5 x 106 cells at 2.5 x 107 cells/ml for 
90 minutes.  Cells were pelleted at 300 g for 4 minutes, the supernatant/nanoparticles 
were removed, and the cells were resuspended in PBS.  Post incubation with the gold 
nanoparticles, the cells were washed twice with 15 ml of PBS, stained with silver 
enhancement solution, and measured for gold content in a 96 well plate reader (Tecan, 
Infinite M200) (Excitation – 310 nm, Emission – 400 nm).  The data were fit to a 
Langmuir binding isotherm with Bmax and Kd nonlinearly fit with Matlab nlinfit.   
 
Nanoparticle Tf Content.  Iron was dechelated from Tf-PEG-OPSS by incubating in 
sodium maleate solution (pH 5.0) for one hour and removing unbound iron with 50 
MWCO spin filters (Amicon).  Iron removal was confirmed by measuring A465/A280 and 
comparing to A465/A280 of holo-Tf.  Tf-PEG-OPSS was resuspended in 50 mM sodium 
bicarbonate (pH 8.0) to which 4 mCi of 64Cu (obtained from Isotope Production Group at 
Washington University, Saint Louis) was mixed and incubated for 90 minutes at room 
temperature.  Tf-PEG-OPSS was concentrated in the 50 MWCO spin filter, and unbound 
copper was removed with a citrate based (pH 7.0) Micro Bio-Spin column (Bio-rad). 
64Cu labeling of Tf was tested and confirmed by instant thin layer chromatography 
(ITLC) (Biodex, Tec-Control).  The concentration of the radiolabeled Tf-PEG-OPSS was 
determined using a Nanodrop 2000 (Thermo), and the Tf-PEG-OPSS was stirred at room 
temperature with the indicated ratio of gold nanoparticles for at least one hour.  Unbound 
Tf was removed by pelleting the nanoparticles through centrifugation and removing the 
Tf-laden supernatant.  The nanoparticles were sonicated and washed with 1.5 ml of water.  
Gamma Activities of each particle formulation were counted with a gamma counter 
(Wizard, Perkin Elmer) and a standard curve of Tf-PEG-OPSS was generated to 
determine the bulk amount of Tf attached to the gold. 
 
Animal Studies. All animals were treated according to the NIH Guidelines for Animal 
Care and Use as approved by the Caltech Institutional Animal Care and Use Committee. 
Female Balb/c mice (Jackson Laboratory) received i.v. doses of nanoparticles in 150 ul of 
PBS through the lateral tail vein.  Injected doses were as follows: 20 nm gold = 5 x 1013 
nanoparticles/mouse, 45 nm gold = 2.9 x 1012 nanoparticles/mouse, 80 nm gold = 4.5 x 
1011 nanoparticles/mouse. When processing for light microscopy and TEM imaging, the 
mice were euthanized by CO2 overdose.  For TEM perfusion fixation analysis, mice were 
deeply anesthetized with 3% isoflurane, the skin over the ventral thorax was incised and 
the thorax opened to expose the heart.  The right atrium was clipped and the left ventricle 
was perfused with 10% sucrose followed by the fixative (4% paraformaldehyde, 0.05% 
glutaraldehyde, 5% Lanthanum Nitrate in 100 mM sodium cacodylate buffer, pH 7.2) at 
300 mm Hg using a Perfusion One perfusion pump system (Leica Neurolabs).  After 
fixation, the brain was removed and placed in 4% paraformaldehyde for further tissue 
processing.  
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Transmission electron microcopy: 500 um vibratome sections were additionally fixed 
in 2.5 % glutaraldehyde (in 0.1 M sodium cacodylate, pH = 7.4) for 2 h, stained by 1 % 
OsO4 on ice for 2 h, and 0.9 % OsO4 and 0.3 % K4Fe(CN)6 at room temperature for 2 h. 
Gradual dehydration with ethanol and propylene oxide enabled tissue embedding in Epon 
812 resins (Ted Pella). Vibratome sections of the fixed brains were flat embedded in 
order to select specific regions of the brain for further sampling.  Cerebral sections of the 
brains were cut from the epoxy block with a diamond wire hand saw and re-embedded in 
epoxy resin for ultramicrotome sectioning.  180 nm thick sections were deposited on 
carbon and formvar-coated, 200-mesh, copper grids (Electron Microscopy Sciences) and 
stained with 3% uranyl acetate and Reynolds lead citrate (15 minutes each) for 
visualization under a 80 kV TF30UT transmission electron microscope (FEI, Tecnai). 
 
Light Microscopy: Resected tissues were fixed in fresh 4% paraformaldehyde (in PBS 
pH 7.0) overnight, dehydrated in increasing concentrations of ethanol (3 x 30 minutes 
each), equilibrated in xylenes (3 x 30 minute washes) and equilibrated in 50% 
xylene/50% molten paraffin (30 minutes).  The tissues were placed in pure molten 
paraffin (3 x 1 hour), placed in a paraffin mold, allowed to cool, and 5 um sections were 
obtained.  Sections were deparafinized with xylenes, rehydrated with serial dilutions of 
ethanol.  To visualize gold nanoparticles, the silver enhancement kit for light and electron 
microscopy (Ted Pella) was used as indicated by the manufacturer – silver enhancement 
was allowed to incubate on the tissue section for approximately 20 minutes.   After 
hematoxylin counterstaining, the sections were re-dehydrated with ethanol and xylenes, 
and mounted with Permount (Fisher). All light microscopy images were taken on an 
Olympus IX50 microscope with a 40x objective using QCapture Pro imaging software 
(QImaging).   
 
Image Analysis, Particle Counting, and Statistics: All images were taken from 
sections as close to the mid sagittal plane as possible (one section imaged per brain).  40 
images were taken of each tissue section, with images taken from throughout four regions 
of the brain (10 images per region): rostral, dorsal, and ventral regions, and the 
cerebellum.  Within each region the images were acquired with a sequential random 
sampling method: beginning from a randomly chosen starting point images were taken at 
set intervals using transverse scans that spanned most of the tissue section.  Nanoparticles 
visualized in the parenchyma and 80 nm nanoparticles visualized in the vessels were 
manually counted and the data was binned in Matlab.  Pairwise comparison groups (e.g. 
80 nm 20 Tf vs. 80 nm 200 Tf) of the non-normal distributions were analyzed for 
statistically significant differences using a Mann-Whitney U test (Wilcoxon rank sum 
test) and p-values reported in Figure 2.  Image brightness and contrast were adjusted 
using "Levels" and "Curves", and all adjustments were applied to the whole image.  In 
some instances (H&E images), color was adjusted using "Levels" to match the other 
images in the figure. This adjustment was applied to the whole image.  All adjustments 
were made using Adobe PhotoShop.  
 
ICP-MS.  Brains were microwaved in aqua regia (70% HNO3 and 30% HCl in a 3:1 
volume ratio) until they were fully homogenized.  20.5 mL of deionized water were 
added and the sample was centrifuged at 3200 g for 15 min to remove cell debris.  The 
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supernatant was analyzed for gold content using an HP 4500 ICP-MS (Agilent). 
Nebulization occurred with a flow of 1.3 L/min of argon using a Babbington type 
nebulizer in a Pyrex Scott-type spray chamber. The argon plasma power was 1200 W 
with a flow of 15 L/min and an auxiliary flow of 1.1 L/min. A calibration curve of 
various concentrations of unmodified gold nanoparticles was used to measure the gold 
content, using 2.5% HNO3 and 0.42% HCl as the blank solvent. Reported values are 
expressed as the percent of injected dose per gram of brain tissue. Error bars represent the 
standard error from the measurements taken from each group of mice. 
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Supplementary Appendix Figures: 
 
Figure S1.  (a) HPLC data with an impure monoPEGylated fraction eluting at the second 
peak.  All unconjugated Tf eluted in the first peak.  (b) HIC performed post HPLC with a 
pure monoPEGylated fraction eluting from the first peak.  (c) MALDI-TOF 
demonstrating a monoPEGylated fraction was obtained (MW = 83 kDa); unPEGylated Tf 
had a MALDI-TOF peak at 78 kDa. 
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Figure S2.  Binding isotherm data for each nanoparticle formulation on Neuro2A cells.  
The model curves are based on Langmuir isotherms, where Kd and Bmax values were 
numerically determined by Matlab nlinfit. 
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Figure S3. Examples of silver enhancement signal observed in the brain parenchyma that 
were not considered to be specific to nanoparticle accumulation due to receptor mediated 
transcytosis.  (a) Some large vessels had an excessive amount of silver enhancement 
signal adjacent to the vessel; likely due to tissue processing.  (b) Rarely, blotching was 
seen (also seen in the untreated brain) due to silver enhancement deposition in the tissue.  
(c) A silver enhancement signal unique to the rostral cortex, the olfactory glomerulus, 
and the cerebellum was observed in some (but not all) sections.  When this staining 
pattern was seen it was difficult to identify nanoparticles, and therefore these 
nanoparticles were not included in the quantitative analysis in order to avoid 
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miscounting. (d) At some of the bordering regions of the brain (both in the ventricles and 
outer periphery of the brain) silver enhancement signal that looked to be from gold 
nanoparticles was present.  It was not certain this signal was from receptor mediated 
transcytosis or artifact from tissue processing, and therefore was not included in the 
quantitative analysis. 
 
Figure S4. Images from the brain of the untreated mouse.  (a) Very rarely, some silver 
enhancement deposited in the tissue resulting in non-specific blotching. (b) Most of the 
brain is clean of silver enhancement deposition in the large vessels, capillaries and 
parenchyma. 
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Figure S5.  Low and high magnification images of 20 nm nanoparticles. 
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Figure S6. Low and high magnification images of 45 nm nanoparticles. 
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Figure S7. Low and high magnification images of 80 nm nanoparticles. 
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